Nov 15 2010
Hansen Medical has declared that it will unveil its latest adaptive catheter vascular robotic system, including an outline of its preclinical analysis and the recently accomplished ‘First in Man Study,’ at the 37th annual VEITH symposium at the Hilton New York, New York City, from November 17 to 21.
Bruce Barclay, President and CEO of Hansen Medical, has stated that VEITH conference is one of the most significant meetings of medical experts from various parts of the world. He mentioned that considering their preliminary research, they believe that their catheter vascular robotic system can profoundly optimize catheter movement. He added that the regulatory submission, approval and commercialization of this robotic technology in the following year will be highly crucial for their company. He further mentioned that this symposium will help them to share their invention with several experts of vascular surgery as well as interventional segment.
Clinicians who performed the First in Man Study investigation will offer presentation at the conference. It was reported that another presentation on the new investigational vascular robotic system of Hansen Medical will be given at the AIMsymposium, organized exclusively for interventionalists. This conference will be conducted concomitantly at the Hilton New York.